Ocular Evidence
Community experiences

What people report after refractive surgery

Search structured details from individual public forum accounts. These are anecdotes, not clinical evidence or estimates of how often an outcome occurs.

Read this layer differently from study results. Posts are self-reported, selectively shared and may be incomplete or inaccurate. We never combine them into complication, satisfaction or success rates.
Reset

202 reviewed experiences

Only curator-approved records with a currently verified source appear here. No usernames or copied post bodies are published.

Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account at 3 weeks described the result. The source included baseline prescription values. Topics included blur or fluctuating vision. The poster's overall assessment was favorable.

Age
44

Reported starting point

Reported prescription values-8 D, -9 D, -4 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 3 weeks · stated by poster
Symptoms discussedblur or fluctuating vision
Both eyes · 3 weeks · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 6/6. Topics included halos, blur or fluctuating vision. The source did not state a clear overall satisfaction judgment.

Reported starting point

Reported prescription values-2.5 D, -2.75 D, -0.5 D
stated by poster
Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values6/6
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account at 1 year described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included starbursts, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-10 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 year · stated by poster
Reported visual-acuity values20/20
1 year · stated by poster
Symptoms discussedstarbursts, blur or fluctuating vision, pain or discomfort
Both eyes · 1 year · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included halos. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/12. Topics included blur or fluctuating vision, pain or discomfort. The source did not state a clear overall satisfaction judgment.

Reported starting point

Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/12
Follow-up reported · stated by poster
Symptoms discussedblur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included ghosting, pain or discomfort, floaters. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Reported prescription values-8.5 D, -0.25 D, -6.75 D, -0.75 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedghosting, pain or discomfort, floaters
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2018

A first-person ICL account at 4 years described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, pain or discomfort. The poster's overall assessment was favorable.

Age
26
Device
Visian ICL

Reported starting point

Reported prescription values-7.5 D, -8 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 4 years · stated by poster
Reported visual-acuity values20/20
4 years · stated by poster
Symptoms discussedhalos, pain or discomfort
Both eyes · 4 years · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2022

A first-person ICL account at 1.5 months described the result. Reported acuity included 20/20, 10/10. Topics included halos, night-vision difficulty. The source did not state a clear overall satisfaction judgment.

Device
EVO ICL

Reported starting point

Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1.5 months · stated by poster
Reported visual-acuity values20/20, 10/10
1.5 months · stated by poster
Symptoms discussedhalos, night-vision difficulty
Both eyes · 1.5 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account at 6 months described the result. Reported acuity included 20/10. Topics included halos, pain or discomfort. The poster's overall assessment was favorable.

Device
Visian ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 6 months · stated by poster
Reported visual-acuity values20/10
6 months · stated by poster
Symptoms discussedhalos, pain or discomfort
Both eyes · 6 months · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account at 2 days described the result. Topics included halos, blur or fluctuating vision, haze, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Device
EVO ICL

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 days · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, haze, pain or discomfort
Both eyes · 2 days · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included halos, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Device
Visian ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included halos. The source did not state a clear overall satisfaction judgment.

Reported starting point

Reported prescription values-9 D, -6.5 D
stated by poster
Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedhalos
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/25. Topics included halos, haze, light sensitivity. The poster's overall assessment was favorable.

Age
36

Reported starting point

Reported prescription values-13.75 D, -3.25 D, -11.75 D, -2.75 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/25
Follow-up reported · stated by poster
Symptoms discussedhalos, haze, light sensitivity
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account at 9 days described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/25. Topics included halos, glare, light sensitivity, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Age
27

Reported starting point

Reported prescription values-11.25 D, -13.75 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 9 days · stated by poster
Reported visual-acuity values20/20, 20/25
9 days · stated by poster
Symptoms discussedhalos, glare, light sensitivity, pain or discomfort
Both eyes · 9 days · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account at 2 days described the result. The source included baseline prescription values. Reported acuity included 20/25, 20/20, 20/16. Topics included blur or fluctuating vision, night-vision difficulty, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Reported prescription values-10 D, -11 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 days · stated by poster
Reported visual-acuity values20/25, 20/20, 20/16
2 days · stated by poster
Symptoms discussedblur or fluctuating vision, night-vision difficulty, pain or discomfort
Both eyes · 2 days · stated by poster
Self-reported anecdoteReported dissatisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included light sensitivity, pain or discomfort. The poster's overall assessment was unfavorable.

Age
24

Reported starting point

Reported prescription values-7 D
stated by poster
Overall self-assessmentunsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedlight sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, blur or fluctuating vision, light sensitivity, night-vision difficulty. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-17.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, light sensitivity, night-vision difficulty, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2022

A first-person ICL account at 6 months described the result. Topics included halos, night-vision difficulty. The source did not state a clear overall satisfaction judgment.

Reported starting point

Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 6 months · stated by poster
Symptoms discussedhalos, night-vision difficulty
Both eyes · 6 months · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included halos, blur or fluctuating vision, haze, light sensitivity. The poster described a mixed result or a recovery with meaningful tradeoffs.

Device
Visian ICL

Reported starting point

Reported prescription values-10 D, -9 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, haze, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20, 20/15. Topics included glare, ghosting, double vision, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.

Device
EVO ICL

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/15
Follow-up reported · stated by poster
Symptoms discussedglare, ghosting, double vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/30. Topics included halos, starbursts, ghosting. The poster described a mixed result or a recovery with meaningful tradeoffs.

Reported starting point

Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/30
Follow-up reported · stated by poster
Symptoms discussedhalos, starbursts, ghosting
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 6/10. Topics included dry eye, halos, blur or fluctuating vision, haze. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-14.5 D, -0.25 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values6/10
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, blur or fluctuating vision, haze, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2022

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included halos, glare, ghosting, blur or fluctuating vision. The poster's overall assessment was favorable.

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, glare, ghosting, blur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2021

A first-person ICL account at 2 weeks described the result. The source included baseline prescription values. The source explicitly reported pre-existing dry eye. Reported acuity included 20/20. Topics included dry eye. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-8.5 D
stated by poster
Pre-existing dry eyeExplicitly reported before the procedure
Both eyes · stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 weeks · stated by poster
Reported visual-acuity values20/20
2 weeks · stated by poster
Symptoms discusseddry eye
Both eyes · 2 weeks · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2021

A first-person ICL account at 3 days described the result. The source included baseline prescription values. Reported acuity included 20/60, 20/40, 20/25, 20/30. Topics included dry eye, halos, glare, blur or fluctuating vision. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-9 D, -1 D, -9.75 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 3 days · stated by poster
Reported visual-acuity values20/60, 20/40, 20/25, 20/30
3 days · stated by poster
Symptoms discusseddry eye, halos, glare, blur or fluctuating vision, night-vision difficulty, pain or discomfort
Both eyes · 3 days · stated by poster